Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Jop Teepen

Postdoc
Subsequent tumors in childhood cancer survivors
Phone 088 97 25 192

Survivors of childhood cancer are at increased risk of late morbidities, including the development of subsequent tumors. More knowledge on risks of and risk factors for subsequent tumors is essential to predict which survivors are at highest and at lowest risk. This is important to guide follow-up recommendations and the development of new treatment protocols of children with cancer. As an epidemiologist, I coordinate various projects on subsequent tumors in childhood cancer survivors, which address clinically-relevant questions and gaps in knowledge. Currently, I am supervising several PhD students and research assistants on different projects:

Supervisor(s): Leontien Kremer


Key Publications:

Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, Jaspers MWM, Hauptmann M, van der Heiden-van der Loo M, Visser O, Kremer LCM, Ronckers CM; DCOG LATER Study Group. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy. J Clin Oncol. 2017 Jul 10; 35(20):2288-2298. doi: 10.1200/JCO.2016.71.6902. Epub 2017 May 22. PubMed PMID: 28530852.

 Teepen JC, Kok JL, van Leeuwen FE, Tissing WJE, Dolsma WV, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, van den Berg MH, van der Heiden-van der Loo M, Hauptmann M, Jongmans MC, Overbeek LI, van de Vijver MJ, Kremer LCM, Ronckers CM; DCOGLATER Study Group. Colorectal Adenomas and Cancers After Childhood Cancer Treatment: A DCOG-LATER Record Linkage Study. J Natl Cancer Inst. 2018 Jul 1; 110(7):758-767. doi: 10.1093/jnci/djx266. PubMed PMID: 29986097.

 Teepen JC, Kok JL, Kremer LC, Tissing WJE, van den Heuvel-Eibrink MM, Loonen JJ, Bresters D, van der Pal HJ, Versluys B, van Dulmen-den Broeder E, Nijsten T, Hauptmann M, Hollema N, Dolsma WV, van Leeuwen FE, Ronckers CM; DCOG-LATER Study Group. Long-Term Risk of Skin Cancer Among Childhood Cancer Survivors: A DCOG-LATER Cohort Study. J Natl Cancer Inst. 2019 Feb 25. doi: 10.1093/jnci/djy212. [Epub ahead of print] PubMed PMID: 30802904; PubMed Central PMCID: PMC6695299.

Teepen JC, Kremer LC, van der Heiden-van der Loo M, Tissing WJ, van der Pal HJ, van den Heuvel-Eibrink MM, Loonen JJ, Louwerens M, Versluys B, van Dulmen-den Broeder E, Visser O, Maduro JH, van Leeuwen FE, Ronckers CM; DCOG-LATER Study Group. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort. Cancer Causes Control. 2019 Sep;30(9):909-922. doi: 10.1007/s10552-019-01204-z. Epub 2019 Jul 12. PubMed PMID: 31300947.

 

  • Clinical evaluation of late outcomes in Dutch childhood cancer survivors

    • jan. 2023
    • Elizabeth A M, Feijen, et al
    • Pediatric blood & cancer
  • Questionnaire- and linkage-based outcomes in Dutch childhood cancer survivors

    • jan. 2023
    • , et al
    • Cancer Medicine
  • The cumulative burden of self-reported, clinically relevant outcomes in long-term childhood cancer survivors and implications for survivorship care

    • jan. 2023
    • , et al
    • Cancer
  • Extensive Cardiac Function Analyses Using Contemporary Echocardiography in Childhood Cancer Survivors

    • jan. 2023
    • , et al
    • JACC: CardioOncology
  • Cohort profile

    • nov. 2022
    • Yuehan, Wang, et al
    • BMJ Open
View all publications